Philippines,
November 2010
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a new administration committed to expanding healthcare access to all sections of the population. The report tackles the issues surrounding the current government’s unpredictability and highlights the country’s successes in areas such as drug accessibility, manufacturing capabilities, and even digital solutions.
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Philippine healthcare and pharma sectors.
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a new administration committed to expanding healthcare access to all sections of the population. The report tackles the issues surrounding the current government’s unpredictability and highlights the country’s successes in areas such as drug accessibility, manufacturing capabilities, and even digital solutions.
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Philippine healthcare and pharma sectors.
